Target- |
MechanismPhotosensitizers |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
/ Not yet recruitingNot ApplicableIIT CLINICAL EFFICACY AND SAFETY OFTAZAROTENE CREAM 0.05% IN THE INITIALAND MAINTENANCE THERAPIES OF LAMELLAR ICHTHYOSIS (LI)
/ Not yet recruitingPhase 2IIT Systemic and local diffusion of ethanol after administration of ethanol 96% formulated in a gel (L0122 Gel) and ethanol 98% solution (absolute ethanol) by the percutaneous route, in patients with congenital venous malformations (CVM): pharmacokinetic, pharmacodynamic and clinical study.
/ Not yet recruitingNot ApplicableIIT Long-term efficacy and safety of V0034 CR 01B cream in patients with moderate-to-severe uremic xerosis.
100 Clinical Results associated with Orfagen
0 Patents (Medical) associated with Orfagen
100 Deals associated with Orfagen
100 Translational Medicine associated with Orfagen